Research

Mixed

Administration of a novel amino acid formulation (AXA2678) containing essential and non-essential amino acids, including N-acetylcysteine, attenuates skeletal muscle atrophy and prevents intramuscular fat accumulation during short-term (7-day) limb immobilization in healthy young men.

If you are facing a period of forced inactivity (like a cast or bed rest), standard protein or leucine supplements may not be enough to stop muscle loss. A specific blend of essential and non-essential amino acids, including antioxidants like NAC, appears to protect muscle mass and prevent fat infiltration in the muscle during short-term immobilization. This is not a substitute for movement, but a mitigation strategy.

ModerateSupportsMEDIUM confidence
Administration of AXA2678 attenuated muscle disuse atrophy compared to PL... During immobilization, muscle FF increased in PL but not in AXA2678... AXA2678 attenuated atrophy, and attenuated accumulation of fat during short-term disuse.
Tanya M. Holloway et al. · Frontiers in Nutrition · 2019

Why this rating

Double-blind randomized controlled trial, but small sample size (n=20) and short duration (7 days immobilization).

Source

A Novel Amino Acid Composition Ameliorates Short-Term Muscle Disuse Atrophy in Healthy Young Men

Tanya M. Holloway et al. · Frontiers in Nutrition · 2019

DOI 10.3389/fnut.2019.00105

rct · n=20Cited 47×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →